echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Gilead poached Amgen R&D executives

    Gilead poached Amgen R&D executives

    • Last Update: 2021-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationFan Dongdong

    According to the latest news, Gilead Sciences has hired Amgen R&D executive Flavius ​​Martin to run Gilead’s R&D department.


    After joining, Martin will serve as Gilead’s Vice President of R&D and will report directly to Gilead’s Chairman and CEO Daniel O'Day.


    Regarding this personnel change, O'Day said, “Flavius ​​has decades of experience in early drug discovery research and identification of promising therapeutic candidates.


    In 2017, Gilead announced that it would acquire Kite Pharma, an anti-cancer drug manufacturing company, at a price of US$180 per share and spend more than US$10 billion, expanding the research and development line of tumor therapy, and spending billions of US dollars to strengthen cooperation and anchoring.


    In addition to the field of oncology, Gilead did not delay its original virology business.


    Reference source: Gilead poaches Amgen exec Flavius ​​Martin to run its R&D as 30-year veteran Bill Lee retires

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.